Psychedelic Pharmacy – New Frontiers in Psychiatry
Oct 15, 2024 - Oct 15, 2025
1 credit
Full course description
Accredited 1 CEU. The emergence of Psychedelic-assisted Therapy (PAT) as a new treatment paradigm for Canadians experiencing end-of-life distress, treatment-resistant depression, and PTSD requires understanding of both safety and efficacy. This session delivers an essential primer on PAT, focussing on psilocybin and MDMA. Through a brief discussion of current clinical research, participants will receive an overview of PAT neuroscience and pharmacotherapy. Review of the current regulatory landscape of PAT in Canada will lead to the emerging role of psychiatric pharmacists in PAT medication management.
Personal information provided on contact, subscription or registration forms is collected pursuant to section 26(c) of the Freedom of Information and Protection of Privacy Act (FIPPA), RSBC 1996, c.165, as amended. The information will only be used for the purposes of UBC‐related programs. UBC collects, uses, retains and discloses information in accordance with FIPPA. UBC may share and disclose personal information within the University to carry out its mandate and operations. Information, in aggregate form only, may also be used for research purposes and statistics.